PMID int64 35.7M 36.4M | Title/Abstract stringlengths 22 8.78k | MeshTerms stringlengths 7 101 | SemanticTypes stringlengths 4 64 |
|---|---|---|---|
36,245,113 | current status sleev gastrectomi plus jejunojejun bypass present sleev gastrectomi sg roux en gastric bypass rygb becom major bariatr metabol surgic procedur neither perfect ad jejunojejun bypass jjb sg enhanc weight loss hypoglycem effect present clinic result show short term weight loss effect sg jjb better sg weight loss hypoglycem effect similar rygb howev sg jjb various complic like tradit jejun ileal bypass jib exist evid show sg jjb safe effect bariatr metabol surgeri relat simpl technic requir meanwhil sg jjb almost dump syndrom ulcer facilit endoscop examin biliari tract blind gastric pouch thus sg jjb clinic applic prospect high qualiti research long term follow need | D015390;D009767 | T061;T047 |
36,245,112 | precis applic sleev gastrectomi improv nation economi live standard preval obes relat metabol diseas increas year treatment effect tradit diet control physic exercis drug therapi ideal metabol bariatr surgeri aim weight loss also improv resolv varieti metabol comorbid type diabet hypertens sleep apnea syndrom hyperlipidemia enhanc qualiti life patient surgic method also updat iter continu develop metabol surgeri weight loss present mainstream procedur laparoscop sleev gastrectomi lsg applic lsg focus precis surgic oper indic avoid reduc advers reaction complic maxim effect bariatr surgeri time standard postop manag multidisciplinari team mdt hospit databas construct dietari nutrit exercis guidanc discharg regular follow review still import guarante weight loss effect | D003924;D010535;D009767 | T061;T047;T060 |
36,245,111 | applic concept precis obes metabol surgeri laparoscop roux en gastric bypass due complex heterogen obes diagnosi treatment obes vari great five percent bodi weight lost lifestyl modif nutrit behavior counsel use approv weight reduct medicin obes diabet howev non surgic treatment effect patient compar medic therapi bariatr surgeri associ higher rate type diabet remiss lower mortal vascular complic long term sustain weight loss advent precis medicin surgic therapi bariatr surgeon fundament understand laparoscop roux en gastric bypass surgeri evolv recent year object surgeri shift short term weight loss safe success long term manag patient weight comorbid laparoscop roux en gastric bypass surgeri concept precis bariatr metabol surgeri main reflect three aspect accur preoper assess precis intraop oper comprehens postop manag new direct futur develop precis laparoscop roux en gastric bypass surgeri obes metabol surgeri formul precis individu surgic treatment plan patient use artifici intellig big data technolog improv standard specialist data | D050110;D003924;D015390;D010535;D009767 | T061;T047;T060 |
36,245,110 | mini gastric bypass one anastomosi gastric bypass year one anastomosi gastric bypass rutledg report first case mini gastric bypass mgb carbajo improv techniqu mgb name one anastomosi gastric bypass oagb past year larg number clinic basic studi oagbmgb report answer key question oagbmgb gradual becom clear technic point view mgb oagb regard two subvari one surgeri advantag oagbmgb includ simplic safeti lower probabl intern hernia stabl durabl weight reduct effect stabl durabl remiss rate type diabet disadvantag oagbmgb includ bile reflux higher risk malnutrit oagbmgb achiev good balanc effect safeti becom notic fastest grow bariatr metabol procedur recent year oagbmgb recommend standard bariatr metabol procedur ifso asmb | D003924;D015390;D009767 | T061;T047 |
36,245,109 | expert consensus standard process imag examin diagnosi gastric cancer edit follow develop individu treatment gastric cancer standard radiolog evalu gastric cancer becom import howev hollow viscera stomach fix shape complex relationship adjac organ upper abdomen lead challeng radiolog detect local diagnosi differenti diagnosi classif stage evalu treatment respons gastric cancer deal challeng address clinic concern consensus includ domest expert frontlin clinic diagnosi treatment gastric cancer invit medic surgic expert particip inspect whole process sort around five key point gastric cancer radiolog evalu includ select modal predispos specif examin standard report regul procedur particip multidisciplinari team expert vote secret ballot determin level evid recommend hope use standard refer radiolog examin diagnosi gastric cancer | D013274 | T191 |
36,245,108 | procedur guidelin laparoscop one anastomosi gastric bypass oagb edit quantiti case metabol obes relat diseas includ obes type diabet china increas year total number exist patient new patient year rate highest world larg amount evid base medic report shown bariatr surgeri effect reduc excess bodi weight patient morbid obes allevi effect seri obes relat metabol comorbid includ type diabet laparoscop one anastomosi gastric bypass oagb current one wide practic bariatr surgeri procedur world although procedur carri patient china year standard surgic oper oagb subject relev guidelin consensus light chines societi metabol bariatr surgeri csmbs recent initi compil first edit procedur guidelin laparoscop one anastomosi gastric bypass edit aim provid unifi specif procedur provid refer surgic oper standard clinician field obes relat metabol surgeri reduc avoid complic caus irregular surgeri ultim benefit patient | D050110;D003924;D015390;D010535;D009767 | T061;T047;T060 |
36,245,107 | chines expert consensus precis obes metabol surgeri edit increas preval obes popular bariatr surgeri patient obes undergo bariatr surgeri precis medicin new generat medic concept introduc concept precis medicin precis bariatr metabol surgeri order optim integr modern surgic theori technolog tradit surgic method requir high precis high effici standard achiev minim trauma invas maxim organ protect minim medic cost best weight loss effect chines societi metabol bariatr surgeri csmbs organ domest bariatr surgeri expert conduct four relev problem orient clinic practic problem includ precis preoper assess precis periop manag precis surgic oper precis postop manag base domest foreign literatur evid combin chines condit clinic experi csmbs formul chines expert consensus precis obes metabol surgeri aim provid guidanc clinic practic precis obes metabol surgeri countri | D050110 | T061 |
36,245,105 | comparison increment shuttl walk test minut walk test cardiopulmonari exercis stress test patient myocardi infarct background studi aim analyz correl among peak oxygen uptak vo cardiopulmonari exercis test cpx increment shuttl walk test iswt minut walk test mwt distanc patient myocardi infarct mi addit aim determin relationship maximum heart rate hrmax rate perceiv exert rpe among test compar chang heart rate verifi clinic benefit submaxim stress test materi method analyz correl use iswt mwt min interv h cpx patient mi differ hrmax rpe test also compar addit chang heart rate analyz use descript statist result iswt distanc strong correl peak vo r ci mwt r ci hrmax cpx demonstr signific correl iswt mwt p iswt r ci stronger correl mwt r ci valu rpe signific differ p howev signific correl chang heart rate mwt plateau initi increas heart rate iswt cpx increas gradual conclus recommend iswt submaxim exercis test evalu exercis capac patient mi | D005080;D009203 | T047;T060 |
36,245,104 | post inject deliriumsed syndrom case report year follow background long act inject lai antipsychot one form therapi sever mental ill post inject deliriumsed syndrom pdss rare serious advers effect follow applic olanzapin long act form common symptom syndrom sedat delirium dysarthria ataxia extrapyramid symptom agit dizzi seizur predisposit prevent exact mechan pdss remain unclear case report present case report year old male patient experienc pdss includ main symptom pdss diagnost method olanzapin plasma concentr therapeut process outcom includ follow patient year later patient long term damag disabl post traumat stress disord follow event includ inform current medic use lai antipsychot updat everyday life conclus pdss life threaten condit clinician must awar easiest precaut h observ applic inject predisposit prevent exact mechan pdss remain unclear import report rare case pdss conduct research safeti patient follow patient show patient well post traumat stress disord follow event continu use lai antipsychot medic | D014150;D003693 | T121;T048;T039 |
36,245,102 | approach de escal antiplatelet treatment stabil post myocardi infarct patient high ischem risk patient acut coronari syndrom ac undergo percutan coronari intervent pci dual antiplatelet therapi dapt potent py inhibitor normal recommend month howev greatest anti ischem benefit dapt occur earli excess bleed event occur chronic treatment de escal dapt emerg treatment strategi ac patient | D062645;D054058;D009203 | T061;T047 |
36,245,101 | role blood pressur manag stroke prevent current status futur prospect stroke second lead caus death worldwid second lead caus disabl adjust life year well known hypertens signific risk factor cardiovascular event includ stroke | D003924;D000077203;D006973;D020521 | T121;T047;T109 |
36,245,096 | melimin modifi print polycaprolacton scaffold prevent biofilm relat biomateri infect biomateri associ infect one major caus implant failur infect result persist bacteria adher biomateri surfac surgeri form biofilm implant surfac estim implant surfac contamin bacteria howev infect rate high intens care unit develop countri high develop countri date clinic solut prevent implant infect without reli use high dose antibiot suppli system andor remov infect devic studi melimin chimer cation peptid test phase ii human clinic trial immobil onto surfac print medic grade polycaprolacton mpcl scaffold via coval bind adsorpt x ray photoelectron spectroscopi xps time flight secondari ion mass spectrometri tof sim spectra melimin treat surfac confirm immobil peptid well homogen distribut throughout scaffold surfac amino acid analysi show melimin coval noncoval immobil result peptid densiti ngcm respect furthermor demonstr immobil melimin mpcl scaffold ethyl dimethylamino propyl carbodiimid hydrochlorid edc coupl noncoval interact result reduct staphylococcus aureus colon respect comparison nonmodifi control specimen particular modifi surfac maintain antibacteri properti day result inhibit biofilm format vitro system offer biomateri strategi effect prevent biofilm relat infect implant surfac without reli use prophylact antibiot treatment | D011550;D023181 | T007;T123;T116;T129 |
36,245,095 | protect effect trifluoromethyl e cinnamoyl l f phenylalanin acid chronic cerebr hypoperfus injuri promot brain deriv neurotroph factor mediat neurogenesi vascular dementia vad one major consequ stroke second reason cognit declin age peopl chronic cerebr hypoperfus cch consid main caus cognit impair vad patient previous studi synthet compound trifluoromethyl e cinnamoyl l f phenylalanin acid ae proven decreas infarct volum recov insuffici blood suppli ischemia reperfus rat remind ae may possess amelior effect cch studi bilater common carotid arteri occlus perform establish cch model rat evalu effect mechan ae cch result show ae mgkg ig could recov learn memori increas number neuron hippocampus may attribut neurogenesi effect recoveri cerebr blood flow cch rat addit vitro studi show ae promot neuron prolifer induc differenti neuro cell neuron like morpholog acceler establish axon dendrit polar primari hippocamp neuron upregul brain deriv neurotroph factor via pikaktcreb pathway conclus ae promis candid treatment cognit declin cch injuri restor blood suppli brain promot neurogenesi hippocampus | D002545;D015140 | T047;T046 |
36,245,092 | synthesi polycycl hetero fuse deazapurin heterocycl nucleosid c h dibenzothiophen negishi coupl new approach synthes polycycl heterofus deazapurin heterocycl correspond nucleosid develop base c h function divers hetero aromat dibenzothiophen oxid follow negishi cross cooupl bis dichloropyrimidin yl zinc cross coupl afford seri het aryl pyrimidin convert fuse deazapurin heterocycl azid thermal cyclize fuse heterocycl glycosyl correspond deoxi ribonucleosid seri deriv prepar nucleophil substitut posit four seri new polycycl thieno fuse deazapurin nucleosid synthes use strategi deoxyribonucleosid show good cytotox activ especi ccrf cem cell line phenyl thienyl substitut thieno fuse deazapurin nucleosid fluoresc former one convert deoxyribonucleosid triphosph enzymat synthesi label oligonucleotid | D009705;D012263 | T121;T114 |
36,245,090 | situ measur atp singl cell amphiphil aptam assist electrochem nano biosensor situ quantit measur adenosin triphosph atp singl live cell high desir understand sever sort necessari physiolog patholog process due small size high sensit ultra microelectrod use singl cell analysi howev atp difficult detect singl cell nonelectroact low content herein introduc electrochem nano biosensor base amphiphil aptam assist carbon fiber nanoelectrod aptcfn high signal nois ratio low current eg pa tini diamet tip ca nm nanosensor made noninvas live cell amphiphil aptam good biocompat stabli modifi surfac function electrod cfne modifi ferrocen label aptam could quick select detect atp content nucleus cytoplasm extracellular space singl hela cell result show atp content nucleus cytoplasm extracellular space respect anticanc drug treatment effect cellular level record great signific understand atp relat biolog process drug screen strategi univers applic detect target chang aptam sequenc great improv understand cell heterogen provid reliabl scientif basi explor major diseas singl cell level | D052157;D015374 | T059;T075;T114 |
36,245,089 | pt tetraphenyl butadien nanocryst coreact acceler crystal induc enhanc electrochemiluminesc ultrasensit microrna detect herein pt tetraphenyl butadien nanocryst pt tpb ncs high electrochemiluminesc ecl effici ecl emitt develop construct ultrasensit biosens platform detect microrna mirna interest pt tpb ncs exhibit high carrier densiti electron mobil achiev effici electron hole pair recombin high ecl emiss also serv coreact acceler endogen coreact dissolv good electrocatalyt activ produc abund reactiv oxygen speci ros facilit interact tpb ncs ros obtain intens ecl emiss impress pt tpb ncs dissolv coreact display high ecl effici ecl take ecl ru bpi dissolv ecl system herein pt tpb ncs strong ecl signal use ecl emitt combin target induc dna walker amplif high convers effici construct ultrasensit ecl biosen platform accomplish microrna detect low detect limit therefor develop synergi effect pt tpb ncs expect guid progress high effici ecl emitt sens analysi diseas diagnosi | D035683;D015374;D053758 | T073;T059;T075;T123;T114 |
36,245,068 | spectrum egfr mutat relat high risk predictor thyroid cancer kashmiri popul year prospect studi tertiari care hospit egfr mutat extens studi thyroid cancer studi conduct studi spectrum egfr mutat thyroid cancer kashmiri popul possibl therapeut purpos | D008175;D013964 | T191 |
36,245,062 | cohort profil food chain plus focus cohort food chain plus focus cohort launch popul base research relat metabol inflamm character novel patholog comprehens manner data collect includ multipl omic layer phenom microbiom metabolom genom metagenom well nutrit profil tast percept phenotyp social network analysi cohort set repres northern german popul kiel region two step recruit includ randomis enrol particip via resid registr offic via obes outpati centr univers medic center schleswig holstein uksh henc popul metabol inflamm base cohort creat total individu analys baselin baselin data collect took place includ femal male age rang year median age particip year iqr year median baselin bmi studi popul kgm iqr kgm baselin cohort particip type diabet mellitus preval subject metabol inflamm group mig follow assess diseas progress well onset new diseas chang subject phenotyp diet lifestyl factor plan everi year first follow period finish includ subject | D003924 | T047 |
36,245,045 | cell imperm staurosporin analog target extracellular kinas inhibit hsv sar cov herp simplex virus hsv receptor engag activ phospholipid scramblas trigger akt transloc outer leaflet plasma membran subsequ phosphoryl promot viral entri hypothes previous unrecogn outsid insid signal pathway employ virus cell imperm kinas inhibitor could provid novel antivir synthes cell imperm analog staurosporin cimss inhibit outer membran hsv induc akt phosphoryl block viral entri without induc apoptosi cimss also block phosphoryl phosphoinositid depend protein kinas phospholipas c gamma detect outer leaflet follow hsv exposur moreov vesicular stomat virus pseudotyp sar cov spike protein vsv nativ vsv vsv pseudotyp ebola virus glycoprotein trigger scramblas akt outer membran signal pathway vsv nativ sar cov infect inhibit cimss thus cimss uncov uniqu extracellular kinas process link hsv sar cov entri | D000086382;D000086402 | T047;T067;T005 |
36,245,043 | hsf driver leukemia stem cell self renew acut myeloid leukemia acut myeloid leukemia aml maintain self renew leukem stem cell lscs fundament problem treat aml convent therapi fail elimin lscs reiniti leukemia heat shock transcript factor hsf central regul stress respons emerg import target cancer therapi use genet hsf delet direct hsf small molecul inhibitor show hsf specif requir mainten aml spare steadi state stress hematopoiesi mechanist delet hsf dysregul multifacet gene involv lsc stem suppress mitochondri oxid phosphoryl downregul succin dehydrogenas c sdhc direct hsf target forc express sdhc larg restor hsf ablat induc aml development defect import growth engraft human aml cell suppress hsf inhibit data provid rational develop efficaci small molecul specif target hsf aml | D000066673;D015470 | T191;T043 |
36,245,042 | immunolog brought periodont diseas recent year recent decad shed new light pathomechan periodont inflamm classic periodontolog concentr biofilm control oral hygien improv profession tooth clean surgic correct damag periodont tissu new aspect destruct mechan rais among greatest attent paid influenc host respons clinic manifest diseas numer studi prove shift gingiv periodont simpl progress diseas event occur suscept individu suscept may result appear local factor facilit biofilm accumul andor matur system featur among reaction prolong agit non specif compon inflammatori respons crucial present paper summar associ periodontolog immunolog updat knowledg accru most recent year brief explan advanc understand diseas aetiolog studi potenti viabl immunolog marker periodont diseas present possibl new therapeut strategi exploit knowledg natur host respons immunomodul reduct chronic oxid stress also present | D005891;D010510;D010518 | T047 |
36,245,040 | spatial snapshot amyloid precursor protein intramembran process via earli endosom proteom degrad recycl plasma membran protein occur via endolysosom system wherein endosom bud cytosol plasma membran subsequ matur degrad lysosom compart method develop rapid select captur lysosom lyso ip analog method isol earli endosom intermedi lack develop approach rapid isol earlysort endosom affin captur earli endosom associ protein eea endo ip provid proteom lipidom snapshot eea posit endosom action identifi recycl regulatori membran fusion complex well candid cargo provid proteom landscap earlysort endosom demonstr util method combin endo lyso ip multiplex target proteom provid spatial digit snapshot amyloid precursor protein app process secretas produc amyloidogen speci quantifi small molecul modul secretas action endosom anticip endo ip approach facilit systemat interrog process coordin eea posit endosom | D053829;D016564 | T126;T116 |
36,245,036 | bovin viral diarrhea virus type c strain china isol identif assess pathogen rabbit bovin viral diarrhea virus bvdv import anim pathogen negat econom impact cattl industri worldwid studi bvdv strain name bj detect isol identifi cattl beij china herd screen bvdv antigen elisa indirect immunofluoresc assay ifa investig genom featur characterist utr region isol sequenc blast analyz bvdv bj belong bvdv c subtyp differ beij preval bvdv strain bvdv particl observ transmiss electron microscopi tem evalu virul bvdv bj bvdv seroneg rabbit intraperiton inocul virus suspens blood sampl analyz chang leukocyt number antibodi titer tissu sampl taken histopatholog analysi data confirm rabbit could act reservoir bvdv pose small non zero risk infect bvdv free cattl herd knowledg first report patholog chang rabbit exposur bvdv c subtyp could act experiment refer meanwhil result studi indic rabbit could act potenti model studi mechan bvdv vivo | D001912;D030241;D001908 | T047;T005 |
36,245,034 | ex vivo engin human plasma cell exhibit robust protein secret long term engraft vivo due uniqu longev capac secret high level protein plasma b cell potenti use cell therapi protein replac show ex vivo engin human plasma cell exhibit singl cell rna profil scan electron micrograph ultrastructur featur vivo home capac long live plasma cell transfer human plasma cell immunodefici mice presenc human cytokin baff il observ increas retent plasma cell bone marrow engraft exceed year profound vivo effect human il observ within day transfer could explain decreas apoptosi newli differenti plasma cell collect result show ex vivo engin differenti human plasma cell potenti long live vivo protein secret model small anim | D018380;D010950 | T061;T025 |
36,245,033 | relationship coronari arteri tortuos cardiorespiratori fit patient without obstruct coronari studi aim analyz relationship cardiorespiratori fit crf increas sever coronari arteri tortuos cat patient non stenos coronari | D000072599;D003324 | T047;T040 |
36,245,031 | latest research advanc danggui buxu tang effect prescript various diseas comprehens review danggui buxu tang dbt compos astragali radix angelica sinensi radix weight ratio recip decoct simpl dbt wide use treatment blood defici syndrom year china studi chemic constitu show saponin flavonoid volatil oil organ acid polysaccharid main compon dbt mani techniqu third generat sequenc pcr denatur gradient gel electrophoresi hplc ms use qualiti control dbt dbt wide rang biolog activ includ blood enhanc antagon diabet nephropathi cardiovascular protect immun stimul estrogen like effect antifibrosi among other paper summar recent research advanc dbt term compon pharmacolog activ possibl mechan action well provid suggest research | D029971;D012503;D009822 | T109;T002 |
36,245,030 | induc er stress pad inhibitor bb cl amidin effect kill aml cell acut myeloid leukemia aml high heterogen recurr hematolog malign despit emerg novel chemotherapi drug aml patient complet remiss cr remain unsatisfactori consequ imper discov new therapeut target medic treat aml epigenet chang like dna methyl histon modif play vital role aml peptidylarginin deminas pad protein famili histon demethylas among pad pad express demonstr elev aml patient thus suggest potenti role pad develop mainten aml potenti identif novel therapeut target | D015470;D009952 | T191;T123;T116;T121 |
36,245,028 | increas cap express stabl chronic obstruct pulmonari diseas cation antimicrobi protein kda cap neutrophil deriv protein origin identifi antimicrobi activ known mani regulatori effect host cell howev role pathogenesi chronic obstruct pulmonari diseas copd studi therefor investig express cap copd effect airway structur cell includ bronchial epitheli cell smooth muscl cell fibroblast | D000890;D029424 | T121;T047 |
36,245,027 | ten year time trend analysi dyslipidemia among adult wuhan dyslipidemia associ increas risk cardiovascular diseas major caus death age popul studi aim estim preval dyslipidemia past decad among adult wuhan china | D050171;D006973 | T047;T046 |
36,245,026 | tran retino acid incorpor glycol chitosan nanoparticl regul macrophag polar pg lps induc inflamm occurr develop inflamm close correl polar macrophag tran retino acid atra proven promot polar macrophag lack effect carrier particip biolog respons present studi aim determin whether retino acid incorpor glycol chitosan ra gc nanoparticl regul macrophag polar porphyromona gingivali lipopolysaccharid pg lps induc inflamm | D008070;D053758 | T109;T073 |
36,245,025 | trib interact stat promot cancer angiogenesi vascular endotheli growth factor vegfa key regul angiogenesi hallmark cancer promot cancer growth metastasi great signific find new intervent target relat regulatori mechan vegfa relat angiogenesi treatment tumor studi focus role tribbl pseudokinas trib signal transduc activ transcript stat vegfa signal axi colon cancer angiogenesi | D042461;D003110 | T191;T123;T116 |
36,245,024 | myeloid deriv suppressor cell activ liver natur killer cell murin model uveal melanoma elev myeloid deriv suppressor cell mdscs mani malign associ increas risk metastas poor prognosi therefor mous model intraocular melanoma establish explor mdscs influenc liver metastas | D000072737;D008545;D008113 | T191;T025 |
36,245,021 | artifact classif apnea event detect neck photoplethysmographi signal novel puls oximetri measur site neck promis locat multi modal physiolog monitor specif context respiratori monitor import direct inform airflow neck make possibl contrast common photoplethysmographi ppg sens site howev ppg signal suscept artifact critic impair signal qualiti fulli exploit neck ppg reliabl physiolog paramet extract apnea monitor paper aim develop two classif algorithm artifact apnea detect featur time correlogram frequenc domain extract two svm classifi rbf kernel train differ window w length threshold thd corrupt artifact classif maximum perform attain paramet combin w thd averag accuraci acc sensit se specif sp apnea detect model w thd maxim perform metric signific acc se sp find proof concept signific denois novel neck ppg signal demonstr first time possibl prompt detect apnea event neck ppg signal instantan manner could make big impact crucial real time applic like devic prevent sudden unexpect death epilepsi sudep | D017156;D016477 | T068;T060 |
36,245,020 | snoar new regress approach remov ocular artifact multi channel electroencephalogram signal electroencephalogram eeg signal often corrupt undesir sourc like electrooculogram eog artifact substanti impact perform eeg base system studi propos new singular spectrum analysi ssa non negat matrix factor nmf base ocular artifact remov snoar method suppress ocular artifact multi channel eeg signal first ssa use estim eog artifact use small subset frontal electrod nmf appli decompos estim eog artifact vertic eog veog horizont eog heog signal final simpl linear regress estim veog heog signal use remov artifact multi channel eeg signal eeg record two eeg dataset klado dataset kara one use evalu effici propos method simul result observ propos method achiev better result term low root mean squar error rmse low delta band energi ratio less power spectral densiti psd differ origin clean eeg signal filter version contamin eeg signal compar select eog artifact remov method independ compon analysi ica wavelet enhanc ica wica improv wica multivari empir mode decomposit memd | D016477;D004569 | T068;T060;T034 |
36,245,013 | quantit character spatial distribut brain metastas breast cancer respect molecular subtyp brain metastas bm remain signific caus morbid mortal breast cancer bc patient specif factor promot process bm predilect select neuro anatom region remain unknown yet may major implic prevent treatment anatom spatial distribut bm bc suggest predomin metastas hindbrain cerebellum systemat approach quantifi bm locat locat base analys base molecular subtyp howev remain larg unavail | D001932;D001943;D016634;D064726 | T191;T061 |
36,245,012 | genom scale model chines hamster ovari cell hybrid semi parametr flux balanc analysi flux balanc analysi fba current standard method comput metabol flux genom scale network sever fba extens employ divers object function andor constraint publish propos hybrid semi parametr fba extens combin mechanist level constraint parametr empir constraint non parametr linear program cho dataset measur exchang flux obtain reactor experi serv evalu method mechanist constraint deduc reduc cho k genom scale network metabolit reaction degre freedom non parametr constraint obtain princip compon analysi flux dataset two type constraint integr linear program show compar comput cost standard fba hybrid fba shown signific improv specif growth rate predict differ constraint scenario metabol effici cell growth feed target minim byproduct accumul design hybrid fba conclud integr parametr nonparametr constraint linear program may effici approach reduc solut space improv predict power fba method critic mechanist inform miss | D053858;D008954 | T169;T044;T075 |
36,245,009 | atf depend fructolysi fuel growth glioblastoma multiform excess consumpt fructos western diet contribut cancer develop howev still unclear cancer cell coordin glucos fructos metabol tumor malign progress demonstr glioblastoma multiform gbm cell switch energi suppli glycolysi fructolysi respons glucos depriv mechanist glucos depriv induc express two essenti fructolyt protein glut aldob select activ translat activ transcript factor atf function genet pharmacolog disrupt atf depend fructolysi signific inhibit growth coloni format gbm cell vitro gbm growth vivo addit atf glut aldob level posit correl gbm specimen poor prognost indic gbm patient work highlight atf depend fructolysi metabol featur potenti therapeut target gbm | D001932;D005909 | T191 |
36,245,005 | bridg therapeut opportun survey italian molecular tumor board workgroup allianc cancer molecular tumor board mtbs match molecular alter target anticanc drug upon failur avail therapeut option special local need like emerg compar analysi mtb network rare report manuscript summar state art activ italian mtbs emerg onlin survey curat allianc cancer acc | D009369 | T191 |
36,245,002 | branenet embed multilay network omic data integr gene express regul differ molecular level includ chromatin access transcript rna matur transport regulatori mechan strong connect cellular metabol order studi cellular system function omic data molecular level generat effici integr propos branenet novel multi omic integr framework multilay heterogen network branenet express scalabl versatil method learn node embed leverag random walk inform within matrix factor framework goal effici integr multi omic data studi differ regulatori aspect multilay process occur organ evalu framework use multi omic data saccharomyc cerevisia well studi yeast model organ | D012313;D012441 | T004;T114 |
36,245,001 | spectral ct periton carcinomatosi ovarian cancer tool differenti diagnosi small nodul detect periton carcinomatosi patient ovarian cancer crucial establish correct therapeut plan debulk surgeri versus neoadjuv chemotherapi often howev nodul periton carcinomatosi small size reticular appear mimic fat strand typic acut inflamm condit hypothesi use dual layer spectral comput tomographi applic virtual monoenerget imag z effect imag might improv detect characteris periton nodul increas sensit diagnost accuraci recent describ oncolog diseas | D010051;D010534 | T191 |
36,245,000 | enhanc radiat induc immunogen cell death activ chimer antigen receptor cell target cd glioblastoma chimer antigen receptor car cell direct solid tumor less effect due part low lost express specif tumor antigen herein develop differ strategi enhanc car cell persist efficaci produc multispecif car vaccin base immunogen cell death icd demonstr ioniz radiat activ stat irf cd axi upregul cd express form immunosuppress tumor microenviron tme enhanc radioresist cd blockad accumul extracellular atp activ nlrp inflammasom dendrit cell via px receptor therebi promot radiat induc icd multispecif car cell vitro prepar elev icd suppress growth xenograft nude mice radiat cd inhibit induc icd glioma stem cell vaccin enhanc car expans peripher blood multifunct tme antitumor effect glioma model multispecif car cell target car tumor antigen vast enhanc function convent car cell stimul nativ immun respons overcom obstacl specif antigen loss low express target cell antitumor therapi | D005909;D000076962 | T191;T192;T116;T129 |
36,244,997 | metabol effect ad exenatid basal insulin therapi target remiss earli type diabet random clinic trial combin glucagon like peptid receptor agonist glp ra basal insulin emerg option initi inject therapi longstand type diabet tdm recogn short term insulin therapi improv beta cell function induc glycem remiss earli tdm hypothes ad short act glp ra exenatid basal insulin earli tdm may enhanc achiev outcom complet week open label parallel arm trial academ hospit individu age year year durat tdm random comput generat sequenc week treatment insulin glargin glar n ii glargin thrice daili lispro glarlispro n iii glargin twice daili exenatid glarexenatid n follow week washout analyz popul particip median year tdm ac consist glar glarlispro glarexenatid oral glucos toler test baselin week week week enabl assess beta cell function insulin secret sensit index issi glycem control mean issi week intervent primari outcom differ across group glarexenatid glarlispro glar p baselin adjust ac week secondari outcom lowest glarexenatid follow glarlispro glar mean vs vs p week washout howev neither baselin adjust ac baselin adjust issi secondari outcom differ group addit outcom rate remiss glarexenatid glarlispro glar p sever hypoglycemia episod conclus ad exenatid basal insulin earli tdm enhanc under beta cell function capac achiev diabet remiss despit yield treatment glycem benefit | D003924 | T047 |
36,244,995 | midpalat sutur bone repair miniscrew assist rapid palat expans adult midpalat sutur mps repair grow patient rpe previous report howev differ young adult patient time pattern mps repair rapid maxillari expans expect aim studi evalu midpalat sutur repair pattern miniscrew assist rapid palat expans marp adult patient | D003393;D010155 | T061;T030 |
36,244,993 | feder learn algorithm general mix effect model glmm horizont partit data distribut sourc paper develop feder solut base two approxim algorithm achiev feder general linear mix effect model glmm paper also propos solut numer error singular issu show two propos method perform well reveal signific paramet distribut dataset compar central glmm algorithm r packag lme baselin model | D000465;D012107 | T081;T170;T169;T062;T096 |
36,244,992 | rare lysosom diseas registri lesson learn three decad real world evid lysosom storag disord lsd rare diseas caus inherit defici lysosom enzymestransport affect newborn individu lsds face long diagnost journey debilit life threaten event occur clinic trial classic descript lsds typic focus common manifest repres vast phenotyp heterogen encount real world experi addit recogn limit understand natur histori diseas progress real world clinic outcom rare lsds collabor partnership pioneer year ago address gap rare diseas registri rdr gaucher fabri mucopolysaccharidosi type pomp repres largest observ databas lsds past thirti year data rdrs help inform scientif understand develop comprehens monitor treatment guidelin creat framework data collect establish standard care overarch goal improv qualiti life affect patient highlight histori process impact rdrs discuss lesson learn futur direct | D016464;D035583 | T047 |
36,244,991 | nerd multichannel neural network predict cellular respons drug integr multidimension data consid heterogen tumor key issu precis medicin predict drug respons individu accumul various type drug informat multi omic data facilit develop effici model drug respons predict howev select high qualiti data sourc design suitabl method remain challeng | D035683;D009369 | T191;T123;T114 |
36,244,990 | neural substrat reward anticip outcom schizophrenia meta analysi fmri find monetari incent delay task dysfunct mesocorticolimb dopaminerg reward system core featur schizophrenia sz yet precis contribut differ stage reward process relev diseas symptomolog fulli understood perform coordin base meta analysi use monetari incent delay task identifi brain region implic differ reward phase function magnet reson imag sz total studi sz control includ reward anticip studi sz control includ reward outcom meta analysi reveal anticip patient show hypoactiv striatum anterior cingul cortex median cingul cortex mcc amygdala precentr gyrus superior tempor gyrus compar control striatum hypoactiv negat associ negat symptom posit associ proport second generat antipsychot user percentag sga user outcom patient display hyperactiv striatum insula amygdala hippocampus parahippocamp gyrus cerebellum postcentr gyrus mcc hypoactiv dorsolater prefront cortex dlpfc medial prefront cortex mpfc hypoact mpfc outcom negat associ posit symptom moder analysi show percentag sga user signific moder associ symptom sever brain activ anticip outcom stage find identifi neural substrat differ reward phase sz may help explain neuropatholog mechan under reward process deficit disord | D014150;D012559 | T121;T048;T039 |
36,244,989 | efficaci formul sarolanermoxidectinpyrantel simparica trio prevent thelazia callipaeda canin eyeworm infect long time known orient eyeworm thelazia callipaeda zoonot nematod infect eye wide rang vertebr host includ dog cat wildlif carnivor lagomorph human high occurr infect europ first case unit state increas scientif interest parasit also repres risk peopl live endem area therefor treatment prevent thelaziosi canin popul advoc reduc risk human infect well assess efficaci formul contain sarolanermoxidectinpyrantel simparica trio administ oral month interv prevent establish infect callipaeda natur infect dog formul moxidectin expect efficaci eyeworm wherea sarolan pyrantel | D004283;D009348;D017205;D013802 | T047;T204 |
36,244,988 | progress flexor tendon sheath infect hand needl punctur surgeri case report flexor tendon sheath infect may due trauma lacer bite common direct inocul sheath kanavel cardin sign flexor tendon sheath infect case consist symmetr swell entir digit digit semi flex postur exquisit tender along cours tendon sheath pain attempt passiv extens digit elev level inflamm marker white blood cell count erythrocyt sediment rate c reactiv protein often found case flexor tendon sheath infect requir immedi diagnosi treatment prevent poor clinic outcom paper report one case sever flexor tendon sheath infect poor outcom requir ray amput affect finger | D013585;D013717 | T047 |
36,244,987 | role cancer associ fibroblast tumorigenesi gastric cancer despit advanc anticanc therapi prognosi gastric cancer gc remain unsatisfactori research recent year shown malign behavior cancer attribut tumor cell part mediat activ cancer stroma control various molecular network tumor microenviron tme cancer associ fibroblast caf one abund mesenchym cell compon stroma extens particip malign develop gc malign caf modul biolog properti tumor cell multipl way includ secret various bioactiv molecul effect paracrin autocrin signal releas exosom direct interact therebi affect gc initi develop howev mark heterogen cellular origin phenotyp function caf tme gc furthermor variat factor protein microrna lncrnas affect interact caf gc cell although potenti molecular mechan still poor understood review aim describ current knowledg cellular featur heterogen caf discuss factor regul caf focus affect gc biolog review provid mechanist insight could inform therapeut strategi improv prognosi gc patient | D000072645;D035683;D062085;D013274 | T191;T025;T123;T114 |
36,244,986 | associ perceiv life satisfact attitud toward life sustain treatment among elder south korea cross section studi amidst rapid popul age south korea enact well die act late among advanc countri public opinion act still clear background studi aim investig factor affect elder individu attitud toward life sustain treatment examin whether attitud toward life sustain treatment relat perceiv life satisfact | D001290;D010549 | T055;T041;T078;T033 |
36,244,984 | diagnost prognost valu ventilatori power pulmonari hypertens ventilatori power novel index could reflect ventil effici peripher blood flow howev clinic valu pulmonari hypertens ph rare discuss present studi aim investig diagnost prognost valu ventilatori power well associ diseas sever ph | D006976 | T046 |
36,244,983 | serum high mobil group box level associ cardiovascular event lower extrem revascular prospect studi diabet popul peripher arteri diseas pad one disabl cardiovascular complic type diabet mellitus inde associ high risk cardiovascular limb advers event high mobil group box hmgb nuclear protein involv inflammatori respons act pro inflammatori cytokin releas extracellular space hmbg associ pad diabet patient aim studi evalu associ serum hmgb level major advers cardiovascular event mace major advers limb event male lower extrem endovascular revascular ler group diabet patient chronic limb threaten ischemia clti | D003924;D057510;D058729 | T061;T047 |
36,244,981 | expert survey coverag characterist pediatr palliat care europ focus home care children life limit condit home care key compon pediatr palliat care howev poor inform avail servic coverag particular countri specif pediatr palliat home care characterist aim studi therefor describ associ pediatr palliat care coverag nation activ obtain detail inform pediatr palliat home care structur differ european countri | D006699;D010166;D010372 | T091;T061;T058 |
36,244,980 | ineffici white matter activ schizophrenia evok intra inter hemispher communic intens cognit task induc ineffici region network respons schizophrenia scz fmri base studi natur focus gray matter appropri titrat visuo motor integr task reliabl activ inter intra hemispher white matter pathway task assess network ineffici without demand intens cognit effort provid first applic framework studi white matter function respons scz event relat fmri data acquir patient nine femal mean age age gender compar control nine femal mean age use poffenberg paradigm rapid visual detect task use induc intra ipsi later visual motor cortex inter hemispher contra later visual motor cortex transfer fmri data pre post process reliabl isol activ white matter use probabilist tractographi base white matter tract intra inter hemispher transfer condit scz evinc hyper activ longitudin transvers white matter tract hyper activ sub region corpus callosum primarili observ inter hemispher transfer evid function ineffici white matter observ conjunct small ms signific increas respons time function ineffici scz observ white matter degre ineffici contextu relat task condit evok simpl detect task without intens cognit process cumul result expand understand dys connect syndrom also extend search biomark beyond tradit realm fmri studi gray matter | D012559;D066127 | T023;T024;T048 |
36,244,978 | contrast life histori respons climat variabl eastern western north pacif sardin popul massiv popul sardin inhabit western eastern boundari world subtrop ocean basin support commerci fisheri popul marin predat sardin popul western eastern boundari current system respond opposit decad scale anomali ocean temperatur mechan differ variabl remain unclear base otolith microstructur high resolut stabl isotop analys show habitat temperatur earli life growth rate energi expenditur metabol optim temperatur import relationship growth rate temperatur remark differ two subpopul western eastern north pacif vari metabol respons environment chang part explain contrast growth respons consist differ life histori trait observ subpopul western eastern boundari current system around south africa growth surviv characterist facilit contrast respons sardin popul climat chang | D057231;D005399 | T013;T070 |
36,244,973 | low dose interleukin improv salivari secret lymphocyt infiltr salivari gland murin model sjgren syndrom effect low dose interleukin il exocrin glandular gland sjgren syndrom unknown aim studi investig effect low dose il salivari gland structur function murin model sjgren syndrom | D012859 | T047 |
36,244,972 | mani facet rasch calibr foot function index revis short form foot function index revis short version ffi rs foot ankl patient report outcom measur prom develop foot function index ffi previous studi estim item paramet multidimension properti limit proper establish measur properti ffi rs multi facet rasch analysi larger sampl would allow robust valid approach improv clinic interpret ffi rs use multidimension perspect therefor purpos studi assess psychometr properti ffi rs prom foot function | D000842;D005528 | T023;T029 |
36,244,970 | depress fatigu activ ibd microbiom perspect bayesian approach faecal metagenom extraintestin symptom common inflammatori bowel diseas ibd includ depress fatigu high preval especi activ diseas potenti due inflamm mediat chang microbiota gut brain axi aim studi investig associ structur function microbiota characterist sever fatigu depress symptom patient activ ibd | D015212;D064307 | T001;T047;T032;T028 |
36,244,968 | network toxicolog molecular dock analys strychnin indic chrm potenti neurotox target improp use strychnin caus death aim studi identifi evalu toxic mechan action associ activ compound strychnin use network toxicolog approach explor potenti pathogen target | D004365;D013331 | T121;T131;T109;T123 |
36,244,964 | injuri prevent program includ plyometr exercis reduc incid anterior cruciat ligament injuri systemat review cluster randomis trial injuri prevent program includ plyometr exercis reduc incid anterior cruciat ligament acl injuri sport | D000070598;D001265;D007718;D059385 | T061;T037 |
36,244,956 | pre clinic valid turbin base ventil invas ventil acut ventil sever acut respiratori syndrom sar coronavirus cov pandem pressur healthcar system exhaust ventil resourc especi resourc restrict object rapid preclin evalu newli develop turbin base ventil name acut invas ventil | D063087;D000086382;D012128 | T061;T047;T067 |
36,244,945 | clinic applic myofasci therapi hors fascia complex intrigu tissu take structur properti loos dens irregular regular fascia function connect separ unit differ structur bodi myofasci dysfunct signific sourc pain categor densif adhes fibrosi digit palpat treatment myofasci disord provid via superfici deep techniqu differ myofasci treatment techniqu includ slow fast techniqu appli differ depth angl rhythm | D006734 | T047 |
36,244,944 | prevent care manag geriatr hors integr therapi hors year age older account signific portion equin popul integr therapi provid import diagnost treatment tool manag maintain health geriatr hors age hors often afflict chronic diseas process difficult effect manag convent medicin approach lamin osteoarthr diagnost therapeut approach use integr therapi acupunctur spinal manipul present articl manag age hors metabol disord musculoskelet pain stiff muscl hyperton | D006734;D005534 | T047 |
36,244,943 | optim health integr medicin poor perform address poor perform issu hors common yet challeng request veterinarian often limit field diagnost therapi choic grow lay popular integr therapi well increas clinic incorpor creat awar clinic applic mani modal show increas evid posit outcom minim harm addit safeti efficaci evalu need integr modal uniqu way perceiv diseas pattern differ modern approach differ perspect use diagnost therapeut either combin convent approach approach fall short | D055048;D000529;D006734 | T061;T047;T091 |
36,244,942 | clinic applic acupunctur equin practic acupunctur inexpens nonpharmacolog modal varieti musculoskelet neurolog intern medicin applic equin practition common use includ back pain colic lamin laryng hemiplegia suprascapular neuropathi although grow bodi literatur support use acupunctur equid remain need robust doubl blind placebo control clinic efficaci trial | D006734;D015670;D003085 | T061;T047;T184;T033 |
36,244,941 | integr approach neck pain dysfunct equin cervic pain dysfunct may difficult diagnos effect manag understand techniqu integr medicin often allow practition observ palpat area pain dysfunct hors evalu way often taught use convent medicin mani integr therapi also may util effect manag hors result comfort function hors | D019547;D006734 | T047;T184 |
36,244,940 | therapeut exercis equin sacroiliac joint pain dysfunct articl provid equin practition review sacroiliac joint pain dysfunct outlin import provid specif prescript safe effect therapeut exercis program continuum clinic dysfunct associ sacroiliac region present prescrib intervent intent encourag practition perform thorough assess sacroiliac joint adjac soft tissu use sound clinic reason formul therapeut exercis plan | D017116;D006734 | T047;T184 |
36,244,939 | tack fit use long ago tack often fell one size fit categori fortun time chang recent year tack becom function also fashion statement articl describ scientif concept saddl bridl bit emphasi clinic sign associ ill fit incorrect use | D006734 | T047 |
36,244,938 | spinal mobil manipul hors grow bodi evid support use spinal mobil manipul techniqu equin practic outcom paramet report across studi includ measur joint motion nocicept muscl tone perform spinal examin procedur includ static dynam assess quantiti qualiti activ passiv movement tier treatment approach recommend stage applic various therapi base eas cost efficaci | D006734 | T047 |
36,244,937 | manag rider rider person injuri impair biomechan dysfunct may detriment hors perform assess rider hors import identifi structur function issu may impact perform ongo program enhanc rider flexibl motor train may use purpos articl provid strategi may use determin rider need assess formal appropri qualifi practition | D006734 | T047 |
36,244,936 | rehabilit propriocept incoordin paresi physiotherapeut exercis aim stimul motor control flexibl stabil regular employ human physic therapi program specif use exercis shown reduc pain reinjuri pursuant equin patient sever core strengthen exercis role activ deep epaxi musculatur subsequ improv postur motor control alter thoracolumbar kinemat investig bait passiv exercis offer opportun facilit stretch dynam phase strengthen static phase exercis blanket recommend regard prescript exercis advis individu patient prescript consid context handler safeti specif rehabilit goal patient abil effect complet exercis | D006734 | T047 |
36,244,935 | integr medicin equin practic integr medicin base model proactiv promot health well rather reactiv sole focus episod diseas process integr medicin incorpor holist approach clinic practic encourag owner involv focus individu care maintain well optim perform diseas prevent health promot prevent care requir differ set clinic skill perspect typic provid tradit veterinari educ product interprofession collabor essenti compon effect deliveri integr medicin servic | D055048;D006734 | T047;T091 |
36,244,933 | clinic applic chines herbal medicin equin practic tradit chines herbal medicin use treatment equin diseas thousand year clinic studi found chines herbal medicin effect treatment varieti equin condit extens toxicolog studi perform chines herb provid guidanc safe administr hors chines herbal medicin may use prevent medicin well integr complementari modal common equin diseas injuri | D004365;D006734 | T121;T047;T123 |
36,244,932 | integr philosophi case manag articl serv introduct integr case manag appli hors mental health pain manag tissu heal integr philosophi pertain combin convent western medicin complementari altern therapi provid best patient care possibl use current avail evid goal improv health patient holist manner | D055048;D006734;D000529 | T061;T047;T091 |
36,244,891 | cancer cell deriv extracellular vesicl glycocod immunoevas recent evid suggest cancer cell deriv extracellular vesicl might facilit immunoevas glycan known play key role immunomodul especi tether biolog membran howev extracellular vesicl glycocod cancer immunoevas remain larg unexplor area promis potenti new putat diagnost therapeut applic | D000067128;D009369 | T191;T026 |
36,244,882 | explor subnat inequ heterogen impact routin measl immunis africa despit vaccin one effect public health intervent persist inequ inequ immunis understand differ subnat vaccin impact help improv deliveri mechan polici analys subnat vaccin coverag measl first dose mcv estim pattern inequ impact repres death avert across countri africa also evalu much impact would improv equit vaccin coverag scenario use coverag data mcv estim number death avert first administr level use ratio death avert per vaccin two mathemat model extrapol impact subnat level next calcul inequ countri measur spread death avert across region account differ popul final use three equit vaccin coverag scenario evalu much impact mcv immunis could improv assum region countri least nation coverag assum region observ maximum coverag assum region least coverag result show progress coverag reduc inequ slow last decad mani african countri three scenario signific number addit death children could prevent year exampl observ maximum coverag scenario global mcv coverag would improv result cri death avert per live birth paper illustr estim impact mcv immunis nation level mask subnat heterogen show consider number death could prevent maximis equit access countri high inequ increas global coverag mcv vaccin | D008457 | T047 |
36,244,881 | interact anti tick vaccin macrocycl lacton improv acaricid efficaci rhipicephalus boophilus microplus canestrini acari ixodida experiment infest cattl southern cattl fever tick scft rhipicephalus boophilus microplus consid import ectoparasit livestock world high financi loss associ direct feed transmiss hemoparasit babesia bovi b bigemina anaplasma marginal unfortun scft mani part world evolv resist market avail pesticid thus drive develop new control technolog vaccin tick use tick gut protein bm shown effect acaricid resist tick techniqu success implement puerto rico control acaricid resist r microplus dairi beef cattl observ puerto rico indic potenti posit interact anti tick vaccin use conjunct system acaricid treatment project control anim studi complet direct compar efficaci anti tick vaccin without system acaricid result show bm anti tick vaccin combin macrocycl lacton moxidectin express synergist interact provid greater longer efficaci either treatment alon | D048494;D056810;D026863;D000712;D001404;D014612;D002418;D013984 | T047;T116;T131;T121;T109;T129;T204 |
36,244,880 | fight poliomyel histori past present hope futur albert sabin miss nobel gift world children polio poliomyel disabl life threaten diseas caus three poliovirus pv serotyp virus spread person person infect person spinal cord caus paralysi regist case poliomyel world occur africa alon global poliomyel erad propos world health organ member state august world wage war coronavirus pandem histor mileston reach africa offici declar polio free import result obtain thank intens larg scale vaccin campaign road far smooth nevertheless accord great effort need made order facilit access vaccin promot implement countri coverag low vaccin hesit high risk spread poliomyel still relev erad virus africa provid us excel opportun commemor mani scientist contribut achiev epoch make goal first jona salk develop kill virus vaccin especi albert sabin launch program mass immunis oral vaccin poliomyel | D011051;D017955 | T047;T005 |
36,244,879 | high dose influenza vaccin prevent hospit due cardiovascular event older adult nurs home post hoc analysi cluster random trial older adult high risk major acut cardiovascular event mace link influenza ill andprevent influenza vaccin unknown whether high dose vaccin might increment reduc risk macew conduct post hoc analysi data collect pragmat cluster random studi nurs home nh random standard dose sd high dose hd influenza vaccin season adult age year older medicar enrol long stay resid includ analysisther statist signific differ hospit mace acut coronari syndrom ac stroke heart failur hd sd arm howev fee servic group particip hd arm signific decreas risk hospit respiratori problem observ medicar advantag grouphigh dose influenza vaccin shown increment protect mace relat standard dose vaccin | D007252;D007251;D002318 | T121;T047;T109;T129 |
36,244,756 | decreas fertil women cesarean scar syndrom associ chronic inflamm uterin caviti chronic inflamm cesarean scar defect contribut secondari infertil women cesarean scar syndrom howev remain unclear situat inflamm uterin caviti women cesarean scar syndrom ambidirect cohort studi aim explor effect inflamm uterin caviti women cesarean scar syndrom infertil singl univers hospit frequenc chronic endometr infertil patient retrospect compar cesarean scar syndrom group non cesarean scar syndrom group frequenc endometriosi also investig patient cesarean scar syndrom underw laparoscopi level tumor necrosi factor interleukin uterin caviti prospect evalu cesarean scar syndrom group women histori cesarean section control group use enzym link immunosorb assay signific differ incid chronic endometr cesarean scar syndrom non cesarean scar syndrom group respect p endometriosi detect patient laparoscopi tumor necrosi factor interleukin level cesarean scar syndrom group signific higher control group p p respect find suggest one caus secondari infertil women cesarean scar syndrom embryo implant failur associ chronic endometr endometriosi chronic inflamm uterin caviti | D004715;D004716;D007246 | T191;T047;T046;T033 |
36,244,734 | heterogen stroke patient system lupus erythematosus object under pathophysiolog vari accord stroke subtyp howev stroke heterogen among patient system lupus erythematosus sle remain unstudi hypothes contribut sle stroke might vari accord subtyp investig associ sle various stroke subtyp method diagnost code electron medic record use identifi patient sle develop acut cerebr infarct intracerebr hemorrhag four tertiari referr hospit intracerebr hemorrhag classifi lobar deep cerebr infarct classifi accord sss toast criteria physician note use identifi sle activ preval compar among stroke subtyp outcom collect patient medic record result common stroke subtyp patient sle undetermin caus follow small arteri occlus cardioaort embol caus lobar hemorrhag deep hemorrhag larg arteri atherosclerosi stroke onset occur period high sle activ patient proport patient high sle activ vari accord stroke subtyp p highest cerebr infarct undetermin caus stroke recurr death observ patient within year initi stroke onset conclus contribut sle stroke vari signific accord stroke subtyp given unfavor prognosi close stroke subtyp specif observ rheumatologist stroke specialist recommend stroke event | D002545;D008180;D020521 | T047;T046 |
36,244,733 | evalu transmur heal low dose comput tomographi enterographi patient crohn diseas object transmur heal th attract attent new therapeut target crohn diseas clinic data th japan introduc low dose comput tomographi enterographi cte monitor method crohn diseas retrospect investig accuraci evalu th cte method among crohn diseas patient underw low dose cte hospit januari march patient underw colonoscopi balloon endoscopi within week includ result radiolog endoscop examin review independ radiologist gastrointestin endoscopist respect concord rate diagnosi cte endoscopi evalu result twenti six patient achiev th kappa index compar th non th group crohn diseas activ index p endoscop heal rate p serum albumin p serum c reactiv protein level p show signific differ among patient show concord diagnosi cte endoscopi achiev th endoscop heal conclus studi provid real world data crohn diseas evalu low dose cte japan th criterion use studi high kappa coeffici use reproduc mani institut | D003424 | T047 |
36,244,730 | anatomi spinal cord cover nerv spinal cord eleg structur serv conduit transfer inform brain peripher nervous system enabl reader understand complex microstructur anatomi creat detail yet approach anatom refer clinician review gross structur featur spinal cord cover nerv also discuss spinal cord develop microscop organ common anatom variant detail anatomi appear current neuroimag techniqu special attent mr imag | D008279;D013116 | T059;T023;T060;T170 |
36,244,729 | thorac lumbosacr spine anatomi review anatomi thorac lumbar sacral spine knowledg normal anatomi vital review imag spine allow detect abnorm find emphas normal appear thorac lumbosacr spine imag focus common imag techniqu comput tomographi magnet reson imag well highlight less common emerg imag techniqu evalu spine | D008159;D013131 | T023 |
36,244,728 | craniocerv junction cervic spine anatomi detail review embryolog deriv anatomi craniocerv junction subaxi cervic spine correl radiolog imag anatomi | D002574 | T023 |
36,244,727 | root neck extracrani vessel anatomi root neck junction anatom structur thorac inlet axilla lower neck detail radiolog anatomi critic area discuss review | D009333 | T029 |
36,244,726 | anatomi neck muscl space lymph node follow articl detail muscular anatomi head neck includ insert origin action innerv organ anatom subunit andor major action articl also describ space head neck includ boundati content final cervic lymph node address accord anatom locat lymphat drainag | D006258;D009334 | T191;T023 |
36,244,725 | anatomi larynx cervic trachea larynx serv gateway upper lower respiratori tract involv task phonat deglutit airway protect familiar complex anatomi larynx critic detect character diseas region especi cancer stage articl review anatomi larynx cervic trachea includ overview cartilag support tissu muscl mucos space neurovascular suppli lymphat follow correl clinic relev anatom site larynx imag techniqu evalu larynx trachea also discuss briefli | D007830;D014132 | T023;T030 |
36,244,724 | anatomi pharynx cervic esophagus pharynx complex muscular structur allow breath swallow well speech common airspac normal imag appear pharynx cervic esophagus challeng given numer interleav surround muscl numer connect articl present imag anatomi pharynx cervic esophagus also discuss clinic relev select anatom structur import signific diseas develop extens | D004947;D010614 | T023 |
36,244,723 | oral caviti salivari gland anatomi knowledg anatomi essenti understand diseas condit oral caviti salivari gland articl intend serv overview oral caviti subsit neighbor salivari gland author cover anatomi lip tongu floor mouth hard palat teeth various mucos area salivari duct appropri radiolog imag along figur serv companion highlight clinic relev practic applic specif anatom locat | D012469 | T023 |
36,244,722 | tempor bone anatomi tempor bone anatomi high complex complic configur minut anatom structur hous dens osseous structur nevertheless robust understand anatomi essenti clinician must accur diagnos describ various patholog exist region articl provid comprehens overview tempor bone anatomi rang larg compon smallest foramina canal cleft | D013701;D014057 | T023;T060 |
36,244,721 | anatomi mandibl temporomandibular joint dentit oral behavior encompass activ movement oral structur rang qualiti oral behavior essenti establish maintain health well key oral behavior includ breath chew swallow speech key hard tissu element involv oral behavior includ mandibl temporomandibular joint dentit articl discuss anatomi interact hard tissu element select soft tissu element associ oral behavior | D003817;D013704 | T023;T030 |
36,244,720 | maxillofaci skeleton facial anatomi articl discuss anatomi develop face one becom familiar layer muscl vessel nerv face embryolog develop face support structur also discuss addit differ clinic manifest facial paralysi highlight | D005145;D012863 | T022;T029 |
36,244,719 | sinonas anatomi imper imag specialist familiar detail multiplanar comput tomographi imag anatomi paranas sinus adjac structur articl review brief radiolog relev embryolog sinonas region discuss imag anatomi nasal caviti paranas sinus radiologist understand import clinic implic identifi numer anatom variat encount region prepar structur report provid surgic road map refer clinician | D010256 | T023;T030 |
36,244,718 | anatomi orbit orbit complex structur hous globe multipl cranial nerv muscl vascular structur support visual sens mani structur delin care detail anatomist remain beyond resolut convent imag techniqu advanc higher resolut mr surfac coil usag thinner section comput tomograph imag abil resolv small structur continu improv allow radiologist provid detail anatom descript preoper pretreat plan | D008279;D009915 | T059;T060;T170;T030 |
36,244,715 | avascular necrosi capit uncommon present carpal avascular necrosi outsid preiser kienbock diseas avascular necrosi avn remain carpal bone rare caus wrist pain disabl natur histori incomplet understood present much avail clinic inform exist form isol case report small case seri although report surgic treatment option numer dearth compar studi long term outcom data guid manag | D002348;D010020 | T023;T046;T047 |
36,244,714 | preiser diseas current concept etiolog manag term preiser diseas typic use describ idiopath avascular necrosi scaphoid number putat etiolog consid rare natur histori fulli understood manag condit base patient factor well stage diseas regard scaphoid surround wrist chapter apprais avail evid aim provid reader framework manag rare condit | D010020;D021361 | T047;T046;T023 |
36,244,713 | arthroscop manag kienbck diseas wrist arthroscopi repres recent develop diagnosi treatment kienbck diseas direct visual lunat adjac carpal articul accur diagnosi obtain ultim precis treatment decis treatment base bypass fuse excis nonfunct articul done less morbid tradit open techniqu use arthroscopi given minim capsular soft tissu scar potenti improv earli pain function recoveri although technic demand long term outcom studi shown benefit arthroscop approach may worth learn curv | D012667;D010020 | T023;T046;T047 |
36,244,712 | wrist salvag procedur treatment kienbock diseas kienbock diseas progress condit character lunat collaps carpal instabl eventu perilun arthriti etiolog like multifactori includ vascular anatom osseus caus case advanc diseas disabl pain limit motion decreas grip strength may present prefer treatment option nonreconstruct wrist proxim row carpectomi prc total wrist arthrodesi total wrist arthroplasti twa follow chapter discuss various surgic option patient advanc kienbock diseas | D002348;D010020 | T023;T046;T047 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.